Chattem, Inc. (NASDAQ:CHTT)
CAPS Rating:
Marketer and manufacturer of a broad portfolio of branded over-the-counter healthcare products, toiletries and dietary supplements including such categories as topical analgesics, medicated skin care products, medicated dandruff shampoos and conditioners.
RSS Headlines
Fool UK
Recs
CHTT is being sued by Lectec corp for patent infringement of Lectec's transdermal patch technology. On Friday, Feb 6th, Lectec filed a preliminary injunction against the defendants. The motion is very strong. Lectec has two re-examined patents...no re-examined patent has ever been found invalid in a court of law. A top legal firm, Radar, and the case is being tried in Texarcana, the rocket-docket that's also very plaintiff friendly in patent infringement lawsuits. Lectec has an expert witness, Dr. Guy. Many other witnesses and documents will come to light.